Refractory Lichen Planus: Success with Dupilumab.
Sign Up to like & getrecommendations! Published in 2024 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llae425
Abstract: Lichen planus (LP) is an autoimmune inflammatory disease typically treated with topical and systemic corticosteroids, but biologics such as dupilumab are emerging as a novel therapeutic treatment. The literature suggests that dupilumab can improve LP… read more here.
Keywords: lichen planus; planus success; refractory lichen; planus ... See more keywords